These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10153482)

  • 1. Value for money? A contingent valuation study of the optimal size of the Swedish health care budget.
    Eckerlund I; Johannesson M; Johansson PO; Tambour M; Zethraeus N
    Health Policy; 1995 Nov; 34(2):135-43. PubMed ID: 10153482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method.
    Tambor M; Pavlova M; Rechel B; Golinowska S; Sowada C; Groot W
    Soc Sci Med; 2014 Sep; 116():193-201. PubMed ID: 25016327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuation of health changes with the contingent valuation method: a test of scope and question order effects.
    Kartman B; Stålhammar NO; Johannesson M
    Health Econ; 1996; 5(6):531-41. PubMed ID: 9003940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Who Would Pay Higher Taxes for Better Mental Health? Results of a Large-Sample National Choice Experiment.
    Johnson FR; Gonzalez JM; Yang JC; Ozdemir S; Kymes S
    Milbank Q; 2021 Sep; 99(3):771-793. PubMed ID: 34375477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Willingness to pay for a reduction in mortality risk after a myocardial infarction: an application of the contingent valuation method to the case of eplerenone.
    Pinto-Prades JL; Farreras V; de Bobadilla JF
    Eur J Health Econ; 2008 Feb; 9(1):69-78. PubMed ID: 17447095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Willingness to pay for antihypertensive therapy--results of a Swedish pilot study.
    Johannesson M; Jönsson B; Borgquist L
    J Health Econ; 1991; 10(4):461-73. PubMed ID: 10117014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the value of large predators in Sweden: a regional stratified contingent valuation analysis.
    Broberg T; Brännlund R
    J Environ Manage; 2008 Sep; 88(4):1066-77. PubMed ID: 17629394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
    Gyrd-Hansen D; Jensen ML; Kjaer T
    Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay and the sensitivity of willingness to pay for interdisciplinary musculoskeletal clinics: a contingent valuation study in Quebec, Canada.
    Poder TG; He J
    Int J Health Econ Manag; 2016 Dec; 16(4):337-361. PubMed ID: 27878690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decision makers' and scientists' opinion about contingent valuation and choice experiments for measuring willingness to pay in health care: results from a survey in Germany.
    Günther OH; König HH
    Int J Technol Assess Health Care; 2006; 22(3):351-61. PubMed ID: 16984064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redistributive effects of Swedish health care finance.
    Gerdtham UG; Sundberg G
    Int J Health Plann Manage; 1998; 13(4):289-306. PubMed ID: 10346051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contingent valuation analysis of willingness to pay to reduce childhood obesity.
    Cawley J
    Econ Hum Biol; 2008 Jul; 6(2):281-92. PubMed ID: 18619930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term fiscal implications of subsidizing in-vitro fertilization in Sweden: a lifetime tax perspective.
    Svensson A; Connolly M; Gallo F; Hägglund L
    Scand J Public Health; 2008 Nov; 36(8):841-9. PubMed ID: 19004901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Europeans' willingness to pay for ending homelessness: A contingent valuation study.
    Loubière S; Taylor O; Tinland A; Vargas-Moniz M; O'Shaughnessy B; Bokszczanin A; Kallmen H; Bernad R; Wolf J; Santinello M; Loundou A; Ornelas J; Auquier P;
    Soc Sci Med; 2020 Jan; 247():112802. PubMed ID: 32045825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of lipid lowering--a feasibility test of the contingent valuation approach.
    Johannesson M
    Health Policy; 1992; 20(3):309-20. PubMed ID: 10118015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Current and Projected Taxpayer Shares of US Health Costs.
    Himmelstein DU; Woolhandler S
    Am J Public Health; 2016 Mar; 106(3):449-52. PubMed ID: 26794173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The random card sort method and respondent certainty in contingent valuation: an exploratory investigation of range bias.
    Shackley P; Dixon S
    Health Econ; 2014 Oct; 23(10):1213-23. PubMed ID: 23922327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. When do the "dollars" make sense? Toward a conceptual framework for contingent valuation studies in health care.
    O'Brien B; Gafni A
    Med Decis Making; 1996; 16(3):288-99. PubMed ID: 8818128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life, health-state utilities and willingness to pay in patients with psoriasis and atopic eczema.
    Lundberg L; Johannesson M; Silverdahl M; Hermansson C; Lindberg M
    Br J Dermatol; 1999 Dec; 141(6):1067-75. PubMed ID: 10606854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-utility analysis from a societal perspective.
    Johannesson M; O'Conor RM
    Health Policy; 1997 Mar; 39(3):241-53. PubMed ID: 10165464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.